GenAI Gains Ground In Japanese Pharma

Multiple Uses Beyond R&D

 
• By Lisa Takagi

Several Japanese pharma firms are developing use cases for GenAI beyond R&D, in some cases boosting their capabilities with an Nvidia-backed supercomputer platform.

Gen AI can reduce and speed workload both R&D and commercial operations, noted several Japanese firm. (Shutterstock)

More from Japan

More from Business